Titan Medical Partners With Institut Hospitalo-Universitaire de Strasbourg for SPORT Feasibility and Validation Studies

TORONTO, ON –(Marketwired – August 22, 2017) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces the signing of an agreement with Institut Hospitalo-Universitaire de Strasbourg (“IHU Strasbourg”) in France for feasibility and validation studies to support Titan’s regulatory applications for the SPORT Surgical System. These studies are expected to commence in the fourth quarter of 2017 and continue into 2018.

David McNally, President and CEO of Titan Medical, said, “We are thrilled to partner with IHU Strasbourg, one of Europe’s premier research and training centers, for continued feasibility and validation studies for the SPORT system. IHU Strasbourg is well known for its Institute of Image-Guided Surgery and is perfectly suited to combine the know-how of renowned surgeons, scientists and healthcare experts in order to provide effective product evaluation, validation and surgical training. IHU Strasbourg is uniquely qualified with a stellar reputation, strong surgeon engagement and convenient access, which we believe will contribute positively to our planned commercialization activities…

Read more: www.titanmedicalinc.com